BioSig Technologies, Inc. announces its intention to offer shares of common stock through an underwritten public offering.
The company intends to use the net proceeds for purchasing gold bullion according to its investment policy and for general corporate purposes.
Clear Street and Needham & Company are acting as joint book-running managers of the offering.
Offer Details
Shares of common stock (or pre-funded warrants) offered through the public offering by BioSig Technologies, Inc.
Use of Proceeds
Net proceeds from the offering will be used to purchase gold bullion and for general corporate purposes.
Book-Running Managers
Clear Street and Needham & Company are the joint book-running managers of the offering.
- The completion of the offering is subject to market conditions, with uncertainties regarding its timing, size, and terms.
- Interested parties are advised to read the preliminary prospectus supplement and accompanying documents before investing.
BioSig Technologies Inc. aims to raise capital through the public offering to support its investment policy and for corporate purposes, under the management of Clear Street and Needham & Company.